Amarin Corp (AMRN) Quote

Bought or Sold?
Did this insider buy or sell shares. Buy would be great! See would be insider trading.

https://archive.fast-edgar.com/20240718/A8BW922CZ22222Z2222J22ZZC32TZ692B262/

I come here because NWBO pumpers come to boards of stocks I own to flog NWBO. Has been happening for years. Look at a chart: pumping NWBO has been a huge loser for anyone who listened for the last 20 years. Stop pumping this loser of an equity and stay here in the echo chamber, please. Not going

SPY Daily:

Heavy pockets of retail long chasing = yellow candles with "R" above
Trap door threats = lows of yellow candles with "R" above
Noted price action marked with timestamped lines

Retail chasing aths since 5/15

8 trap doors activated

Who spoke on the PODCAST for NSAV. WHO IS THEY?

Of course they are non-reporting company., and non-audit. How convenient they went from a 1.5 million active user to 500 k, allegedly anyway.

In all honesty, I just ignore it. I see it and glance over it. I was loyal for a very long time. Right now, im just shaking my head at how all.this has taken a turn.

You of all people know that we use to but heads and how much I thought about this company. Look at my past messages, bu

Fiduciary malfeasance. The whole operation is a fleecing sham. IMO.

Nice close. Countdown for Saudi product demonstration.

https://scontent-bos5-1.xx.fbcdn.net/v/t39.30808-6/451863632_889597699707421_1102592256106954810_n.jpg?stp=dst-jpg_s640x640&_nc_cat=106&ccb=1-7&_nc_sid=127cfc&_nc_ohc=4g2mdYgSLA4Q7kNvgG4NzkI&_nc_ht=scontent-bos5-1.xx&oh=00_AYBmssnBnN_ea5ZDKHtbBY67Y1O-m2n2MNaRMHBowj2TDg&oe=66A18DC4

DaJester I appreciate your contribution to our cause. My understanding the SCOTUS did not validate the Net Worth Sweep. The Supreme Court basically said we will not rule or give Judgment or act as an arbitrator on the contract the SPSPA, So, the NWS was not validated as legal or illegal by the Court

Yep, blood red in the streets here man, a total disaster. Old Ron hoodwinked unsophisticated retail penny stock investors again. Lol

SPY Daily:

Heavy pockets of retail long chasing = yellow candles with "R" above
Trap door threats = lows of yellow candles with "R" above
Noted price action marked with timestamped lines

Retail chasing aths since 5/15

8 trap doors activated

Arguing on all day on Ihub who's right is probably more entertaining and keeps minds occupied while we all wait. lololsss

99.42%ShortHavok-to-BorrowRate🟩25.26WHOPPING $DBMMers! 0UT
4Real this time though
https://fintel.io/ss/us/dbmm#:~:text=Latest-,2024%2D04%2D02,18.44,-2024%2D04%2D01
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif

Maybe “Next Week”. 🧐🤔

VPLM is the only company in history with patents that are claimed to be worth "billions and billions ongoing" (meaning Microsoft type numbers and revenue) with a price per share below .02 and no one outside this board that speaks about the company. That tells you all that you need to know about what

The podcast was last night. They finally got it up there at about 9:15 mountain time, 11:15 eastern.

Some points:
They are not concentrating on the replacement CEO at this time. They are concentrating on crypto, the exchange, projects, etc. In other words, business and buildi

Bruh, what’s with the all CAPS multi-post rant?
Someone needs a hug 🤗

You misspelled unemployment.

Try again. If you're persistent and ask thoughtful questions he should get back to you.

Everyone should reach out.

inCourtUnder0ath✅D0H! resortstoBashing$DBMM+Mgmt(D0H! Br. at 25-28.)

$DBMM has obtained resources to complete the re-audit, bring the Company current, & continue its timely filings,

DOE once again rejects the Law Judge’s analysis and conclusion that
the

Fosun made two press releases in April and July 2023 in regard to the submission of Daxxify, for cosmetic treatment and the treatment of cervical dystonia, stating that China's NMPA accepted both applications for review. Other source state that median approval for compounds was 15,4 months (2017 -2

Things are taking a while, but if things are good, it'll be worth it, and if things are bad, not so. The only real question is, are you willing to take the risk? And can you afford it if it doesn't work out?

Completely agree . There is no other logical way out given that there has been no concerted effort to even have application ready for other RAs, global infrastructure for staff education/ training / supply chain , any concrete time for other trials etc etc . So please pardon the market if it is not

https://www.mondaq.com/unitedstates/patent/1495098/federal-circuit-provides-insight-on-induced-infringement-claims-in-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc